Skip to main content
Nature Communications logoLink to Nature Communications
. 2019 Feb 15;10:862. doi: 10.1038/s41467-019-08770-5

Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation

Jun Yan 1,2,3, Qingnan Zhao 3, Konrad Gabrusiewicz 4, Ling-Yuan Kong 4, Xueqing Xia 3, Jian Wang 5, Martina Ott 4, Jingda Xu 6, R Eric Davis 6, Longfei Huo 3, Ganesh Rao 4, Shao-Cong Sun 7, Stephanie S Watowich 7, Amy B Heimberger 4,, Shulin Li 3,
PMCID: PMC6377651  PMID: 30770835

Correction to: Nature Communications  10.1038/s41467-018-08271-x, published online 25 Jan 2019.

The original version of this Article contained errors in the author affiliations.

Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.

This has now been corrected in both the PDF and HTML versions of the Article.

Contributor Information

Amy B. Heimberger, Email: aheimber@mdanderson.org

Shulin Li, Email: sli4@mdanderson.org.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES